HIV in Europe is a pan-European initiative initiated in Brussels in 2007
Initiative aim: HIV in Europe is a pan-European multi-stakeholder initiative that works to ensure that people living with HIV and viral hepatitis enter care earlier in the course of their infection than is currently the case, as well as to study the decrease in the proportion presenting late for care. It aims to inform policy processes, share knowledge and improve the evidence base around important issues of earlier testing and care. The initiative is led by an independent group of experts from civil society, policy makers, health professionals and European public health institutions. The initiative has several projects (e.g. OptTEST, European HIV Hepatitis Testing Week)
Coordination: Rigshospitalet – University of Copenhagen- CHIP Department of Infectious Diseases, (Coordinating Secretariat); European AIDS Treatment Group (Advocacy Secretariat); AIDS Fonds Netherlands (Financial Management).
Duration: Started in 2007, ongoing
Main funding source: Unrestricted funding provided by Gilead Sciences, MSD, Tibotec, Pfizer, Schering-Plough, Abbott, Boehringer Ingelheim, Bristol-Myers Squibb, GlaxoSmithKline, ViiV Healthcare and the Swedish Research Council.
EATG contact person(s): Ann Isabelle von Lingen (EATG Office) at email@example.com;
Brian West and Nikos Dedes (EATG membership) at Steering Committee level